Stay-on-Therapy Supportive-Care Kit for First-Line Sacituzumab Govitecan

A ready-to-deploy supportive-care protocol for community oncology practices prescribing first-line sacituzumab govitecan in triple-negative breast cancer — proactive white-count monitoring, G-CSF triggers, early diarrhea management, and nurse triage — built to keep patients on a drug whose benefit depends on staying on it.